June 22, 2020 / 12:11 PM / 10 days ago

FACTBOX-The race for a coronavirus vaccine

 (Updates Inovio, Gamaleya vaccines; adds Bharat Biotech, PLA)
    June 30 (Reuters) - More than 100 vaccines are being developed
and tested around the world to stop the COVID-19 pandemic, which has
killed hundreds of thousands and ravaged the global economy.
    The following is a list of major drugmakers and research
institutes that have started or are planning to start human trials
for their vaccine candidates.
    For a separate FACTBOX on treatments under development, click
here:
        
 Date of  Company       Progress      Development stage   Story link
 last                                                     
 update                                                   
 June 10  Johnson &     Moved up      Trial will take     [nL4N2DN30
          Johnson       human         place in the        1]
                        clinical      United States and   
                        trials for    Belgium.            
                        its                               
                        experimental                      
                        COVID-19                          
                        vaccine by                        
                        two months                        
                        to second                         
                        half of                           
                        July.                             
 June 14  AstraZeneca   Has signed    Mid-stage studies.  [nL4N2DL1B
          Plc           deals to                          3]
                        expand                            
                        future                            
                        supply of                         
                        the vaccine                       
                        it licensed                       
                        from                              
                        University                        
                        of Oxford.                        
                        Currently                         
                        expects to                        
                        supply more                       
                        than two                          
                        billion                           
                        doses.                            
                        Vaccine                           
                        still being                       
                        tested.                           
 June 4   Novavax Inc   The U.S.      Early-stage         [nL4N2DI06
                        Department    testing.            9]
                        of Defense                        
                        has pledged                       
                        $60 million                       
                        to fund                           
                        manufacturin                      
                        g of its                          
                        experimental                      
                        vaccine.                          
 June 18  Sinopharm     The Chinese   Early-to-mid stage  [nL4N2DT36
                        state-owned   trials.             3]
                        company is                        
                        developing                        
                        two                               
                        vaccines,                         
                        one of which                      
                        has shown                         
                        promise in                        
                        humans.                           
 April    BioNTech SE   The German    Being tested in     [nL8N2CI8N
 30                     drugmaker is  humans in early-    W]
                        working with  to mid-stage        
                        Pfizer Inc    trials.             
                                to                        
                        make 10-20                        
                        million                           
                        doses of an                       
                        experimental                      
                        vaccine by                        
                        the end of                        
                        2020.                             
 June 10  Moderna Inc   Lonza         Plans to start      [nL8N2DF4N
                                      late-stage trials   7]
                        aims to       in July.            
                        speed                             
                        completion                        
                        of two                            
                        commercial                        
                        production                        
                        lines for                         
                        Moderna's                         
                        trial                             
                        COVID-19                          
                        vaccine.                          
 May 22   CanSino       Early         Being tested in a   [nL1N2D412
          Biologics     results       mid-stage trial in  J]
                        showed the    Wuhan.              
                        China-based                       
                        company's                         
                        vaccine is                        
                        safe and                          
                        induces a                         
                        rapid immune                      
                        response.                         
 May 14   GlaxoSmithKl  Partnered     Early stage trials  [nL8N2CW42
          ine Plc       with Sanofi   to begin in second  M]
                        SA            half of 2020.       
                        to develop a                      
                        vaccine.                          
 June 17  CureVac       The unlisted  Launched            [nL8N2DU29
                        German        early-stage human   Y]
                        biotech       trial.              
                        expects data                      
                        in September                      
                        or October                        
                        and is                            
                        eyeing                            
                        potential                         
                        approval of                       
                        its vaccine                       
                        in mid-2021.                      
 June 30  Inovio        Vaccine       Mid-stage testing   [nL4N2E737
          Pharma        candidate,                        Q]
                        found to be                       
                        safe,                             
                        induced                           
                        immune                            
                        responses in                      
                        healthy                           
                        volunteers                        
                        in an early                       
                        stage study                       
 June 11  Sinovac       The           Plans to begin      [nL1N2DO1D
          Biotech Ltd   China-based   late-stage trials   Q]
                        vaccine       in Brazil.          
                        maker has                         
                        released                          
                        positive                          
                        preliminary                       
                        results from                      
                        early-stage                       
                        trials of                         
                        its vaccine.                      
 June 19  Clover        The Chinese   Launched human      [nL4N2DW1W
          Biopharmaceu  developer     trials.             I]
          ticals        expects                           
                        initial                           
                        safety data                       
                        from an                           
                        early-stage                       
                        study in                          
                        August and                        
                        aims to                           
                        begin                             
                        broader                           
                        studies by                        
                        the                               
                        year-end.                         
 June 15  Not           Scientists    Early-stage         [nL8N2DS5J
          applicable    at Imperial   trials.             I]
                        College                           
                        London are                        
                        set to begin                      
                        trials of a                       
                        potential                         
                        coronavirus                       
                        vaccine.                          
 June 21  Not           Researchers   Mid-stage trials.   [nL4N2DY03
          applicable    at Institute                      I]
                        of Medical                        
                        Biology at                        
                        Chinese                           
                        Academy of                        
                        Medical                           
                        Sciences are                      
                        testing a                         
                        coronavirus                       
                        vaccine.                          
 June 19  Genexine Inc  South         Early-stage         [nL4N2DW1T
                        Korea's       trials.             3]
                        Genexine has                      
                        begun human                       
                        trials of                         
                        its vaccine.                      
 June 23  Chongqing     The Chinese   Early-stage trial.  [nL4N2E018
          Zhifei        company's                         D]
          Biological    unit Anhui                        
          Products      Zhifei                            
                        Longcom                           
                        Biopharmaceu                      
                        tical has                         
                        received                          
                        approval to                       
                        test its                          
                        vaccine on                        
                        humans.                           
 June 18  Not           The Gamaleya  Early-stage         (bit.ly/2Z2XMEx)
          applicable    Research      trials.             
                        Institute in                      
                        Russia has                        
                        begun human                       
                        trials of an                      
                        experimental                      
                        vaccine,                          
                        with results                      
                        expected in                       
                        August.                           
 June 29  Bharat        Vaccine       Early- to           [nL4N2E70F
          Biotech       approved for  mid-stage trials    6]
                        human trials  to start in July.   
                        in India.                         
 June 24  Walvax        Trials        Early-stage         [nL1N2E11Q
          Biotechnolog  sponsored by  studies.            8]
          y Co          the                               
                        China-based                       
                        company,                          
                        along with a                      
                        Chinese                           
                        military                          
                        research                          
                        institute,                        
                        have begun.                       
 
 (Reporting by Vishwadha Chander and Manas Mishra in Bengaluru;
Editing by Saumyadeb Chakrabarty and Maju Samuel)
  
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below